Etheal’s Development Roadmap
As we near the end of our public sale, we’re gearing up for life after ICO
Our ICO is still on for a few days, but we’re already working on the development and we have a clear roadmap. With the help and input of our amazing community, we were able to quickly hit our minimum cap goal and raise enough funds to bring Etheal to life.
Etheal’s Roadmap:
Now, we’re working full steam on implementation, migrating to the blockchain, developing the product and building our team to reach profitability as soon as possible. Here’s the breakdown of what that will look like.
The Four ‘Nobel’ Releases. We’ve broken down the next year of work into four phases, named after Nobel Prize Winners that were medical doctors and scientists whose work helped shape the world we live in today for the better.
- Behring Release. The goal: To reach and grow profitability
- Sir Ronald Ross Release. The goal: To grow traffic.
- Finsen Release. The goal: To grow conversion.
- Pavlov Release. The goal: To expand to 30 countries.
The Behring Release
About Emil Behring
Emil Behring was a German physiologist who received the first Nobel Prize awarded for physiology or medicine in 1901. The award was in recognition for his discovery of a diphtheria antitoxin, which helped eliminate a major cause of child mortality. His discovery also earned him the moniker ‘Saviour of Children.’
The Etheal team has long been inspired by Hungarian medical pioneers like Albert Szent-Györgyi the discoverer of Vitamin C, and Ignaz Semmelweis the ‘Saviour of Mothers,’ and pioneer of antiseptic procedures. Continuing this tradition, Behring’s work resonates with us as we work to build a product that drastically lowers the research costs of diseases cutting lives short around the world.
About the Behring Release
In the first phase after our ICO, we are focused on building and directing our team towards reaching profitability. Also we can bring “new money” to the crypto economy!
Our previous work building a partner network of clinics and doctors already provides the infrastructure we need to realise profit. So we don’t need to invest in a larger sales team pushing increasing leads, but can focus on driving leads instead.
On a team level, we are growing at a rapid rate, and are continuously looking for the best developers out there to work with. Take a look at our careers page here.
Behring Release: High Level Goals
95% of crypto projects suffer from a failure of adoption— the hype they create is big, but they fail to communicate with and reach a mainstream audience. Their future ultimately rests on corporate investors to maintain momentum.
During the Behring Release, Etheal’s focus will be on reaching medical professionals and healthcare industry stakeholders, and bringing them into the crypto world. The openness to understanding and implementing blockchain in the industry is huge, and we aim to tap into the crowd to secure a steady stream of both new users and new crypto investors.
Behring Features
Here is a list of planned feature developments during the Behring release:
- Translation of the current Hungarian and Portugese sites to: English, German and French.
- Token Membership: the HEAL token’s first utility function. Doctors and clinics with HEAL tokens will get a ‘verified’ profile on their doklist.com listing and can pay for patient leads with HEAL. Membership can be acquired by staking HEAL tokens purchased during the token sale, or on crypto exchanges.
- Inquiries: Patients will be able to request appointments or price proposals. This isn’t just a feature for patients, but also a key part of our Pareto Sales Model. Our partner clinic network will be able to pay for patient leads when we launch the pilot.
In Summary
The Behring Release will:
- Develop and launch token membership for HEAL token holders
- Implement the technical features needed to fuel Etheal’s Pareto Sales model
- Pilot our Pareto Sales model with our existing network of medical practitioners
- Develop and test our sales process with our current partner network, and thus build a strong foundation for long-term profitability.
Stay tuned for updates about the Behring Relase as well as the next release phases in our timeline:
- Behring — Q3 2018
- Sir Ross — Q4 2018
- Finsen — Q1 2019
- Pavlov — Q2 2019
